A Long-term Follow-up Study of Participants Who Received an Allogeneic CAR T-Cell Product
About the study
The goal of this study is to collect information on the long-term safety of study participants who received Allogeneic Chimeric Antigen Receptor (CAR) T-Cell Product in a Precision BioSciences, Inc. (PBI) Clinical Study. The main questions it aims to answer are:
-What were the frequency, severity, duration, and outcome of clinically significant Clinical Events of Interest (CEI)?
Participants will visit a study center 3 times during the first year, and once per year after that for a physical exam and other assessments to check for CEI.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Receipt of at least 1 dose of PBCAR product in a PBI clinical study.
- A signed informed consent form (ICF).
- Willingness and ability to adhere to the study schedule and all other protocol requirements.
EXCLUSION CRITERIA
Exclusion Criteria:
* No unique exclusion criteria apply to this study.
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study Details
Contition
Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
Age
18 - 95
Participants Needed
75
Est. Completion Date
Dec 31, 2039
Treatment Type
OBSERVATIONAL
Sponsor
Precision BioSciences, Inc.
ClinicalTrials.gov NCT Identifier
NCT05822427
Study Number
PBCAR-LTF
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?